Andrew J. D'Silva

CIK: 0002083717

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)7 (77.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OPRX

OptimizeRx Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

OPRX
OptimizeRx Corp
Oct 1, 2026
Tax Payment(F)
Direct
414 shares at avg. $8.39$3K
OPRX
OptimizeRx Corp
Sep 1, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $7.86$11K
OPRX
OptimizeRx Corp
Aug 21, 2026
Tax Payment(F)
Direct
1.2K shares at avg. $7.71$10K
OPRX
OptimizeRx Corp
Aug 20, 2026
Award(A)
Direct
57.6K shares-
OPRX
OptimizeRx Corp
Dec 19, 2025
Tax Payment(F)
Direct
703 shares at avg. $13.51$9K
OPRX
OptimizeRx Corp
Dec 11, 2025
Tax Payment(F)
Direct
868 shares at avg. $14.03$12K
OPRX
OptimizeRx Corp
Oct 3, 2025
Tax Payment(F)
Direct
794 shares at avg. $18.75$15K
OPRX
OptimizeRx Corp
Oct 1, 2025
Tax Payment(F)
Direct
414 shares at avg. $18.98$8K
OPRX
OptimizeRx Corp
Aug 21, 2025
Award(A)
Direct
10.4K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	OPRX OptimizeRx Corp	Tax Payment(F)	414	$8.39	$3,473	Direct
Sep 1, 2026	OPRX OptimizeRx Corp	Tax Payment(F)	1,432	$7.86	$11,256	Direct
Aug 21, 2026	OPRX OptimizeRx Corp	Tax Payment(F)	1,243	$7.71	$9,584	Direct
Aug 20, 2026	OPRX OptimizeRx Corp	Award(A)	57,600	-	$0	Direct
Dec 19, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	703	$13.51	$9,498	Direct
Dec 11, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	868	$14.03	$12,178	Direct
Oct 3, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	794	$18.75	$14,888	Direct
Oct 1, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	414	$18.98	$7,858	Direct
Aug 21, 2025	OPRX OptimizeRx Corp	Award(A)	10,417	-	-	Direct

1-9 of 9 transactions

About D'Silva Andrew J.

D'Silva Andrew J. (SEC CIK 0002083717) files insider reports with the SEC as Chief Business Officer of OptimizeRx Corp (OPRX).

Signal8 holds 9 ownership filings by D'Silva Andrew J. (1 Form 3, 8 Form 4), filed between Oct 7, 2025 and Oct 2, 2026. Those filings report 9 transactions, from Aug 21, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on D'Silva Andrew J.'s filings is in WALTHAM, MA.

Recent filings by D'Silva Andrew J.

Oct 1, 2026: Tax withholding of OPRX shares (Form 4, code F).
Sep 1, 2026: Tax withholding of OPRX shares (Form 4, code F).
Aug 21, 2026: Tax withholding of OPRX shares (Form 4, code F).
Aug 20, 2026: Grant or award of OPRX shares (Form 4, code A).
Dec 19, 2025: Tax withholding of OPRX shares (Form 4, code F).

Other insiders filing for OptimizeRx Corp (OPRX)

Silvestro Stephen L, Chief Executive Officer
Merrell Brendan W., CHIEF OPERATING OFFICER
Odence-Ford Marion, Chief Legal & Admin Officer
Stelmakh Edward, Chief Finance & Strat Officer
KLEMA CATHY, Director
Lang James Paul, Director

How to read Form 4 transaction codes